These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11576078)

  • 21. Evaluation of the antihistamine effects of olopatadine and levocetirizine during a 24-h period: a double-blind, randomized, cross-over, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
    Takeo T; Kasugai C; Tanaka R; Ando T; Ogawa A; Akita Y; Watanabe D
    J Dermatol; 2013 Dec; 40(12):987-92. PubMed ID: 24303975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humans.
    Church MK
    Inflamm Res; 2011 Dec; 60(12):1107-12. PubMed ID: 21874559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
    Carey W; Warrington S; Boyce M; Luria X
    Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of montelukast (10mg daily) and loratadine (10mg daily) on wheal, flare and itching reactions in skin prick tests.
    Kupczyk M; Kupryś I; Górski P; Kuna P
    Pulm Pharmacol Ther; 2007; 20(1):85-9. PubMed ID: 16516511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis.
    Passalacqua G; Canonica GW
    Clin Ther; 2005 Jul; 27(7):979-92. PubMed ID: 16154477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin.
    Purohit A; Melac M; Pauli G; Frossard N
    Br J Clin Pharmacol; 2003 Oct; 56(4):388-94. PubMed ID: 12968983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil.
    Maciel-Guerra H; Penha MÁ; Jorge MFS; Libório RDS; Carrijo ACNDA; Parise-Fortes MR; Miot HA
    An Bras Dermatol; 2018 Mar; 93(2):233-237. PubMed ID: 29723372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of on-site and photographic evaluations of the suppressive effects of cetirizine, loratadine, and fexofenadine on skin response to histamine lontophoresis: A double-blind, crossover study in healthy volunteers.
    Tsuda H; Takiwaki H
    Curr Ther Res Clin Exp; 2005 Jul; 66(4):307-22. PubMed ID: 24672131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
    Stübner P; Zieglmayer R; Horak F
    Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
    Purohit A; Mélac M; Pauli G; Frossard N
    Br J Clin Pharmacol; 2002 Mar; 53(3):250-4. PubMed ID: 11874388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
    Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of levocetirizine, desloratidine and fexofenadine by histamine wheal suppression test.
    Dhanya NB; Thasleem Z; Rai R; Srinivas CR
    Indian J Dermatol Venereol Leprol; 2008; 74(4):361-3. PubMed ID: 18797058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
    Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J
    J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours.
    Passalacqua G; Guerra L; Compalati E; Massacane P; Rogkakou A; Zanella C; Baena-Cagnani R; Canonica GW
    Int Arch Allergy Immunol; 2004 Oct; 135(2):143-7. PubMed ID: 15345913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
    Meltzer EO; Gillman SA
    Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects.
    Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP
    Allergy; 2000 Sep; 55(9):888-91. PubMed ID: 11003455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topically applied aspirin decreases histamine-induced wheal and flare reactions in normal and SLS-inflamed skin, but does not decrease itch. A randomized, double-blind and placebo-controlled human study.
    Thomsen JS; Benfeldt E; Jensen SB; Serup J; Menné T
    Acta Derm Venereol; 2002; 82(1):30-5. PubMed ID: 12013195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects.
    Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP
    Allergy; 2000 Apr; 55(4):382-5. PubMed ID: 10782524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.